SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001531
Filing Date
2023-08-03
Accepted
2023-08-03 14:14:48
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20230630x10q.htm   iXBRL 10-Q 1035463
2 EX-31.1 qnrx-20230630xex31d1.htm EX-31.1 15666
3 EX-31.2 qnrx-20230630xex31d2.htm EX-31.2 15648
4 EX-32.1 qnrx-20230630xex32d1.htm EX-32.1 7551
5 EX-32.2 qnrx-20230630xex32d2.htm EX-32.2 7278
  Complete submission text file 0001410578-23-001531.txt   4831438

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20230630.xsd EX-101.SCH 45780
7 EX-101.CAL qnrx-20230630_cal.xml EX-101.CAL 33042
8 EX-101.DEF qnrx-20230630_def.xml EX-101.DEF 180767
9 EX-101.LAB qnrx-20230630_lab.xml EX-101.LAB 365934
10 EX-101.PRE qnrx-20230630_pre.xml EX-101.PRE 284557
64 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20230630x10q_htm.xml XML 617368
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 231139311
SIC: 3841 Surgical & Medical Instruments & Apparatus